Ozer H - Search Results

1

2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline.

Smith TJ, Khatcheressian J, Lyman GH, Ozer H, Armitage JO, Balducci L, Bennett CL, Cantor SB, Crawford J, Cross SJ, Demetri G, Desch CE, Pizzo PA, Schiffer CA, Schwartzberg L, Somerfield MR, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, Wolff AC. Smith TJ, et al. Among authors: ozer h. J Clin Oncol. 2006 Jul 1;24(19):3187-205. doi: 10.1200/JCO.2006.06.4451. Epub 2006 May 8. J Clin Oncol. 2006. PMID: 16682719

2

Neutropenia and neoplasia: an overview of the pharmacoeconomics of sargramostim in cancer therapy.

Desch CE, Ozer H. Desch CE, et al. Among authors: ozer h. Clin Ther. 1997 Jul-Aug;19(4):847-65. doi: 10.1016/s0149-2918(97)80108-7. Clin Ther. 1997. PMID: 9377627

3

First-Cycle CSF use in breast cancer and NHL: guidelines and recommendations.

Al-Kali A, Ozer H. Al-Kali A, et al. Among authors: ozer h. Oncology (Williston Park). 2006 Dec;20(14 Suppl 9):7-12. Oncology (Williston Park). 2006. PMID: 17370923 Free article. Review.

4

Final results of a placebo-controlled study of filgrastim in small-cell lung cancer: exploration of risk factors for febrile neutropenia.

Crawford J, Glaspy JA, Stoller RG, Tomita DK, Vincent ME, McGuire BW, Ozer H. Crawford J, et al. Among authors: ozer h. Support Cancer Ther. 2005 Oct 1;3(1):36-46. doi: 10.3816/SCT.2005.n.023. Support Cancer Ther. 2005. PMID: 18632435

5

Management of platinum-based chemotherapy-induced acute nausea and vomiting: is there a superior serotonin receptor antagonist?

Hamadani M, Chaudhary L, Awan FT, Khan JK, Kojouri K, Ozer H, Tfayli A. Hamadani M, et al. Among authors: ozer h. J Oncol Pharm Pract. 2007 Jun;13(2):69-75. doi: 10.1177/1078155207078137. J Oncol Pharm Pract. 2007. PMID: 17873106

6

American Society of Clinical Oncology guidelines for the use of hematopoietic colony-stimulating factors.

Ozer H. Ozer H. Curr Opin Hematol. 1996 Jan;3(1):3-10. doi: 10.1097/00062752-199603010-00002. Curr Opin Hematol. 1996. PMID: 9372045

7

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials.

Wasan HS, Gibbs P, Sharma NK, Taieb J, Heinemann V, Ricke J, Peeters M, Findlay M, Weaver A, Mills J, Wilson C, Adams R, Francis A, Moschandreas J, Virdee PS, Dutton P, Love S, Gebski V, Gray A; FOXFIRE trial investigators; SIRFLOX trial investigators; FOXFIRE-Global trial investigators; van Hazel G, Sharma RA. Wasan HS, et al. Lancet Oncol. 2017 Sep;18(9):1159-1171. doi: 10.1016/S1470-2045(17)30457-6. Epub 2017 Aug 3. Lancet Oncol. 2017. PMID: 28781171 Free PMC article. Clinical Trial.

8

Perspectives in the treatment of colorectal cancer.

Ozer H, Diasio RB. Ozer H, et al. Semin Oncol. 2004 Dec;31(6 Suppl 15):14-8. doi: 10.1053/j.seminoncol.2004.11.023. Semin Oncol. 2004. PMID: 15726534 Review.

9

Low incidence of neutropenic events in patients with lymphoma receiving first-cycle pegfilgrastim with chemotherapy: results from a prospective community-based study.

Noga SJ, Choksi JK, Ding B, Dreiling L, Ozer H. Noga SJ, et al. Among authors: ozer h. Clin Lymphoma Myeloma. 2007 May;7(6):413-20. doi: 10.3816/CLM.2007.n.020. Clin Lymphoma Myeloma. 2007. PMID: 17621407 Clinical Trial.

10

New directions in the management of chemotherapy-induced neutropenia: Risk models, special populations, and quality of life.

Ozer H. Ozer H. Semin Oncol. 2003 Aug;30(4 Suppl 13):18-23. doi: 10.1016/s0093-7754(03)00315-4. Semin Oncol. 2003. PMID: 14508716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

593 results

Search Page